Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Opaleye Management Inc., holds the title of 10% Owner at Grace Therapeutics, Inc..
On 2026-11-17, the insider transacted 48,060 shares.The shares were transacted at a weighted average price of $1.74 per share, resulting in a total market-relevant value of $83K.
Opaleye Management Inc. (10% Owner) bought $83K of $GRCE
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.